| Latency reversal agents affect differently the latent reservoir present in distinct CD4+ T subpopulations J Grau-Expósito, L Luque-Ballesteros, J Navarro, A Curran, J Burgos, ... PLoS pathogens 15 (8), e1007991, 2019 | 162 | 2019 |
| Short-course toll-like receptor 9 agonist treatment impacts innate immunity and plasma viremia in individuals with human immunodeficiency virus infection L Vibholm, MH Schleimann, JF Højen, T Benfield, R Offersen, ... Clinical Infectious Diseases 64 (12), 1686-1695, 2017 | 161 | 2017 |
| Peripheral and lung resident memory T cell responses against SARS-CoV-2 J Grau-Expósito, N Sánchez-Gaona, N Massana, M Suppi, ... Nature communications 12 (1), 1-17, 2021 | 152 | 2021 |
| CD32 is expressed on cells with transcriptionally active HIV but does not enrich for HIV DNA in resting T cells M Abdel-Mohsen, L Kuri-Cervantes, J Grau-Exposito, AM Spivak, RA Nell, ... Science translational medicine 10 (437), 2018 | 132 | 2018 |
| Resident memory T cells are a cellular reservoir for HIV in the cervical mucosa J Cantero-Pérez, J Grau-Expósito, C Serra-Peinado, DA Rosero, ... Nature communications 10 (1), 1-16, 2019 | 124 | 2019 |
| A novel single-cell FISH-flow assay identifies effector memory CD4+ T cells as a major niche for HIV-1 transcription in HIV-infected patients J Grau-Expósito, C Serra-Peinado, L Miguel, J Navarro, A Curran, ... MBio 8 (4), 2017 | 105 | 2017 |
| Expression of CD20 after viral reactivation renders HIV-reservoir cells susceptible to Rituximab C Serra-Peinado, J Grau-Expósito, L Luque-Ballesteros, ... Nature communications 10 (1), 1-15, 2019 | 55 | 2019 |
| Evaluation of SARS-CoV-2 entry, inflammation and new therapeutics in human lung tissue cells J Grau-Expósito, D Perea, M Suppi, N Massana, A Vergara, MJ Soler, ... PLoS pathogens 18 (1), e1010171, 2022 | 27 | 2022 |
| The thioacetate-ω (γ-lactam carboxamide) HDAC inhibitor ST7612AA1 as HIV-1 latency reactivation agent R Badia, J Grau, E Riveira-Muñoz, E Ballana, G Giannini, JA Esté Antiviral research 123, 62-69, 2015 | 27 | 2015 |
| Zinc pyrithione is a potent inhibitor of PLPro and cathepsin L enzymes with ex vivo inhibition of SARS-CoV-2 entry and replication J Kladnik, A Dolinar, J Kljun, D Perea, J Grau-Expósito, M Genescà, ... Journal of Enzyme Inhibition and Medicinal Chemistry 37 (1), 2158-2168, 2022 | 23 | 2022 |
| Identification of HIV-reservoir cells with reduced susceptibility to antibody-dependent immune response A Astorga-Gamaza, J Grau-Expósito, J Burgos, J Navarro, A Curran, ... Elife 11, e78294, 2022 | 21 | 2022 |
| Atlas of the HIV-1 Reservoir in Peripheral CD4 T Cells of Individuals on Successful Antiretroviral Therapy C Gálvez, J Grau-Expósito, V Urrea, B Clotet, V Falcó, MJ Buzón, ... Mbio 12 (6), e03078-21, 2021 | 19 | 2021 |
| Entrectinib—A SARS-CoV-2 Inhibitor in Human Lung Tissue (HLT) Cells A Peralta-Garcia, M Torrens-Fontanals, TM Stepniewski, J Grau-Expósito, ... International journal of molecular sciences 22 (24), 13592, 2021 | 16 | 2021 |
| Immunomodulatory Activity of the Tyrosine Kinase Inhibitor Dasatinib to Elicit NK Cytotoxicity against Cancer, HIV Infection and Aging A Rodríguez-Agustín, V Casanova, J Grau-Expósito, S Sánchez-Palomino, ... Pharmaceutics 15 (3), 917, 2023 | 11 | 2023 |
